Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1,384 $ 75,890,295 $ 152,803 $ (37,473,580) $ 38,570,902
Balance (in Shares) at Dec. 31, 2019 13,846,925        
Common stock issued for cash $ 1 72,499 72,500
Common stock issued for cash (in Shares) 12,292        
Shares issued upon exchange of common stock equivalents $ 41 (41)
Shares issued upon exchange of common stock equivalents (in Shares) 410,170        
Beneficial conversion feature on convertible debt issued   329,300 329,300
Comprehensive loss:          
Net loss (2,381,260) (2,381,260)
Other comprehensive income (1,844,205) (1,844,205)
Balance at Mar. 31, 2020 $ 1,426 76,292,053 (1,691,402) (39,854,840) 34,747,237
Balance (in Shares) at Mar. 31, 2020 14,269,387        
Shares issued upon exchange of common stock equivalents $ 6 (6)
Shares issued upon exchange of common stock equivalents (in Shares) 56,743        
Comprehensive loss:          
Net loss 267,382 267,382
Other comprehensive income 867,244 867,244
Balance at Jun. 30, 2020 $ 1,432 76,292,047 (824,158) (39,587,458) 35,881,863
Balance (in Shares) at Jun. 30, 2020 14,326,130        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the financing, net of financing costs $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (in Shares) 2,564,000        
Offering costs allocated to warrant liabilities 604,118 604,118
Warrants issued in connection with private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809        
Stock based compensation:          
Common stock $ 20 925,384 925,404
Common stock (in Shares) 197,790        
Options 1,092,399 1,092,399
Comprehensive loss:          
Net loss (16,198,585) (16,198,585)
Other comprehensive income 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) $ 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt (in Shares)         32,500
Balance at Jun. 30, 2021 $ 3,106 89,495,704 1,232,721 (88,015,359) $ 2,716,172
Balance (in Shares) at Jun. 30, 2021 31,061,354        
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Stock based compensation:          
Common stock $ 4 378,655 378,659
Common stock (in Shares) 37,515        
Options 344,095 344,095
Comprehensive loss:          
Shares issued to settle accounts payable $ 23 1,973,227 1,973,250
Shares issued to settle accounts payable (in Shares) 225,000        
Impact of transfer agent reconciliation $ 28 (28)
Impact of transfer agent reconciliation (in Shares) 280,509        
Correction of an error (see Note 11) 363,523 363,523
Net loss   (23,459,136) (23,459,136)
Other comprehensive income 406,487 406,487
Balance at Jun. 30, 2021 $ 3,106 $ 89,495,704 $ 1,232,721 $ (88,015,359) $ 2,716,172
Balance (in Shares) at Jun. 30, 2021 31,061,354